|
1
|
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.
|
Am J Kidney Dis
|
1999
|
3.00
|
|
2
|
One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study.
|
Diabetes Metab
|
2007
|
1.88
|
|
3
|
Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria.
|
Diabetes Care
|
1992
|
1.48
|
|
4
|
Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
|
J Clin Invest
|
1997
|
1.40
|
|
5
|
Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.
|
Diabet Med
|
2008
|
1.38
|
|
6
|
Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients.
|
Diabet Med
|
2001
|
1.31
|
|
7
|
Diabetes and inflammation: fundamental aspects and clinical implications.
|
Diabetes Metab
|
2010
|
1.19
|
|
8
|
Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
|
Diabetes Care
|
2000
|
1.17
|
|
9
|
Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
|
Diabetes Care
|
1999
|
1.17
|
|
10
|
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group.
|
J Am Soc Nephrol
|
1999
|
1.10
|
|
11
|
Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets.
|
J Nutr
|
1997
|
1.06
|
|
12
|
Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation.
|
Eur J Clin Nutr
|
1995
|
1.06
|
|
13
|
An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.
|
Diabetes
|
1999
|
1.04
|
|
14
|
Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
|
Diabetes Metab
|
2007
|
1.02
|
|
15
|
Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker.
|
Diabete Metab
|
1991
|
1.00
|
|
16
|
Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital.
|
Biochem J
|
1991
|
0.99
|
|
17
|
Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.
|
Diabetes Metab
|
2004
|
0.97
|
|
18
|
Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
|
Diabetes Obes Metab
|
2009
|
0.97
|
|
19
|
Multicenter randomized evaluation of a nutritional education software in obese patients.
|
Diabetes Metab
|
2001
|
0.96
|
|
20
|
Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets.
|
Diabetologia
|
1998
|
0.94
|
|
21
|
Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin.
|
Cell Death Dis
|
2011
|
0.94
|
|
22
|
Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report.
|
Diabet Med
|
2010
|
0.94
|
|
23
|
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications.
|
Diabetes Metab
|
2004
|
0.92
|
|
24
|
Neuro-endocrine disorders seen as triggers of the triad: obesity--insulin resistance--abnormal glucose tolerance.
|
Diabetes Metab Rev
|
1985
|
0.92
|
|
25
|
High prevalence of obstructive sleep apnoea syndrome in a Type 1 diabetic adult population: a pilot study.
|
Diabet Med
|
2010
|
0.90
|
|
26
|
Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome.
|
Eur Respir J
|
2008
|
0.87
|
|
27
|
How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey.
|
Diabetes Metab
|
2009
|
0.87
|
|
28
|
Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients.
|
Eur J Clin Invest
|
2004
|
0.87
|
|
29
|
Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions.
|
Diabetes Metab
|
2000
|
0.86
|
|
30
|
Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.
|
Diabetes Obes Metab
|
2009
|
0.85
|
|
31
|
Heat stress fails to protect myocardium of streptozotocin-induced diabetic rats against infarction.
|
Cardiovasc Res
|
1999
|
0.85
|
|
32
|
Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
|
Diabetes Metab
|
2006
|
0.84
|
|
33
|
Plasma 15-F2t isoprostane concentrations are increased during acute fructose loading in type 2 diabetes.
|
Diabetes Metab
|
2008
|
0.84
|
|
34
|
Albumin antioxidant capacity is modified by methylglyoxal.
|
Diabetes Metab
|
2005
|
0.84
|
|
35
|
[Leg ulcer and Klinefelter syndrome].
|
J Mal Vasc
|
1995
|
0.84
|
|
36
|
Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude Study.
|
Diabetes Metab
|
2012
|
0.83
|
|
37
|
Lipid peroxidation and trace element status in diabetic ketotic patients: influence of insulin therapy.
|
Clin Chem
|
1993
|
0.83
|
|
38
|
Differential effect of steady-state hyperinsulinaemia and hyperglycaemia on hepatic glycogenolysis and glycolysis in rats.
|
Diabetologia
|
1987
|
0.83
|
|
39
|
Cortico-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): about two case reports characterized by a gap between the diagnosis of autoimmune thyroiditis and neurological disorders.
|
Ann Endocrinol (Paris)
|
2007
|
0.82
|
|
40
|
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes.
|
Diabetologia
|
2010
|
0.82
|
|
41
|
2'-deoxyguanosine oxidation is associated with decrease in the DNA-binding activity of the transcription factor Sp1 in liver and kidney from diabetic and insulin-resistant rats.
|
Free Radic Biol Med
|
2001
|
0.81
|
|
42
|
Future trends of management of renal failure in diabetics.
|
Kidney Int Suppl
|
1993
|
0.81
|
|
43
|
Predictors of response to glimepiride in patients with type 2 diabetes mellitus.
|
Diabetes Metab
|
2001
|
0.81
|
|
44
|
Impact of diabetes mellitus on clinical presentation and prognosis of pancreatic cancer.
|
Ann Endocrinol (Paris)
|
2010
|
0.81
|
|
45
|
Zinc prevents the structural and functional properties of free radical treated-insulin.
|
Biochim Biophys Acta
|
1994
|
0.81
|
|
46
|
Pattern of plasma levels of cortisol, dehydroepiandrosterone and pregnenolone sulphate in normal subjects and in patients with homozygous familial hypercholesterolaemia during ACTH infusion.
|
Clin Endocrinol (Oxf)
|
1986
|
0.80
|
|
47
|
WHO-5, a tool focusing on psychological needs in patients with diabetes: the French contribution to the DAWN study.
|
Diabetes Metab
|
2012
|
0.80
|
|
48
|
Zinc and insulin sensitivity.
|
Biol Trace Elem Res
|
1992
|
0.80
|
|
49
|
Vitamin D deficiency and peripheral diabetic neuropathy.
|
Eur J Intern Med
|
2011
|
0.79
|
|
50
|
Cardiovascular complications in type 1 diabetes mellitus.
|
Diabetes Metab
|
2010
|
0.79
|
|
51
|
Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide.
|
Clin Nephrol
|
1992
|
0.78
|
|
52
|
A prospective study of quality of life in 77 type 1 diabetic patients 12 months after a hospital therapeutic educational programme.
|
Diabetes Metab
|
2008
|
0.78
|
|
53
|
Basal insulin dose in 40 type 1 diabetic patients remains stable 1 year after educational training in flexible insulin therapy.
|
Diabetes Metab
|
2010
|
0.78
|
|
54
|
Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.
|
J Endocrinol Invest
|
1994
|
0.78
|
|
55
|
High fructose-fed rats: a model of glomerulosclerosis involving the renin-angiotensin system and renal gelatinases.
|
Ann N Y Acad Sci
|
1999
|
0.78
|
|
56
|
Methodological aspects of crossover and maximum fat-oxidation rate point determination.
|
Diabetes Metab
|
2008
|
0.78
|
|
57
|
ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
|
Nephrol Dial Transplant
|
1998
|
0.77
|
|
58
|
Comparison of dinner with bedtime administration of insulin glargine in type 1 diabetic patients treated with basal-bolus regimen.
|
Diabetes Metab
|
2007
|
0.77
|
|
59
|
Insulin sensitivity in zinc-depleted rats: assessment with the euglycaemic hyperinsulinic clamp technique.
|
Diabete Metab
|
1991
|
0.77
|
|
60
|
Standardization of procedure for efficient ex vivo gene transfer into porcine pancreatic islets with cationic liposomes.
|
Transplantation
|
1997
|
0.77
|
|
61
|
Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats.
|
Arterioscler Thromb Vasc Biol
|
2001
|
0.76
|
|
62
|
Variations of ambulatory blood pressure with position in patients with type 1 diabetes: influence of disease duration and microangiopathy in a pilot study.
|
Diabetes Care
|
2001
|
0.76
|
|
63
|
Strategies for graft immunomodulation in islet transplantation.
|
Diabetes Metab
|
1998
|
0.76
|
|
64
|
Assessment of handicap in chronic dialysis diabetic patients (Uremidiab section study).
|
Scand J Rehabil Med
|
1992
|
0.76
|
|
65
|
Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
|
J Clin Endocrinol Metab
|
1987
|
0.76
|
|
66
|
Role of ACE inhibitors in patients with diabetes mellitus.
|
Drugs
|
2001
|
0.76
|
|
67
|
How patients' attitudes and opinions influence self-care behaviours in type 2 diabetes. Insights from the French DIABASIS Survey.
|
Diabetes Metab
|
2010
|
0.76
|
|
68
|
Elevation of serum IgA is of little diagnostic utility in patients with type 2 diabetes mellitus and nephropathy.
|
Nephron
|
1999
|
0.75
|
|
69
|
[Malignant carotid paraganglioma. A case report].
|
Ann Otolaryngol Chir Cervicofac
|
2003
|
0.75
|
|
70
|
A methodology for an efficient and reproducible gene transfer into porcine islets using cationic liposomes.
|
Transplant Proc
|
1997
|
0.75
|
|
71
|
[Diabetic glomerulopathy].
|
Rev Prat
|
1991
|
0.75
|
|
72
|
Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study).
|
Nephrol Dial Transplant
|
1992
|
0.75
|
|
73
|
[Growth hormone stimulation with L. Dopa].
|
Nouv Presse Med
|
1972
|
0.75
|
|
74
|
[Which coronary tests to use in asymptomatic diabetics?].
|
Arch Mal Coeur Vaiss
|
2000
|
0.75
|
|
75
|
[Acute neurologic complications of hypophyseal adenomas].
|
Rev Med Interne
|
1981
|
0.75
|
|
76
|
[Ovarian carcinoma manifested by organic hypoglycemia].
|
Nouv Presse Med
|
1979
|
0.75
|
|
77
|
[Pellagra-like erythema following vertical banded gastroplasty for morbid obesity].
|
Ann Chir
|
2000
|
0.75
|
|
78
|
[Identifying myocardial ischaemia in diabetics. SFC/ALFEDIAM joint recommendations].
|
Arch Mal Coeur Vaiss
|
2004
|
0.75
|
|
79
|
Effects of ritanserin, a specific serotonin-S2 receptor antagonist, on the release of anterior pituitary hormones during insulin-induced hypoglycemia in normal humans.
|
J Endocrinol Invest
|
1995
|
0.75
|
|
80
|
[Is the metyrapone test no longer useful in the evaluation of anterior pituitary corticotropin deficiency?].
|
Presse Med
|
1985
|
0.75
|
|
81
|
Information and therapeutic education of diabetic patients in French hospitals: the OBSIDIA survey.
|
Diabetes Metab
|
2010
|
0.75
|
|
82
|
Effects of a myocardial ischaemia-guided therapeutic program on survival and incidence of coronary events in asymptomatic patients with diabetes: the ARCADIA study.
|
Diabetes Metab
|
2007
|
0.75
|
|
83
|
Insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM).
|
Diabetes Res Clin Pract
|
1988
|
0.75
|
|
84
|
[Use of insulin in non-insulin-dependent diabetes (diabetes type 2). Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].
|
Diabete Metab
|
1995
|
0.75
|
|
85
|
[Erythrocyte aggregation in vivo and diabetic microangiopathy. Physiopathologic determinants and clinical correlations].
|
Diabete Metab
|
1990
|
0.75
|
|
86
|
Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories.
|
Diabetologia
|
1993
|
0.75
|
|
87
|
Health policies and epidemiology of diabetes among dialysed patients in France.
|
Nephrol Dial Transplant
|
1999
|
0.75
|
|
88
|
[Familial form of hypoglycemia due to leucine hypersensitivity].
|
Pediatrie
|
1990
|
0.75
|
|
89
|
[Editorial].
|
Ann Endocrinol (Paris)
|
2005
|
0.75
|
|
90
|
[Apropos of the recommendation for the drug therapy of type 2 diabetes. Conversation with Prof. S. Halimi].
|
Presse Med
|
1999
|
0.75
|
|
91
|
[Glucose and insulin in glucose homeostasis in the liver].
|
Journ Annu Diabetol Hotel Dieu
|
1985
|
0.75
|
|
92
|
[Possible role of opioid peptides in the control of energy homeostasis].
|
Journ Annu Diabetol Hotel Dieu
|
1985
|
0.75
|
|
93
|
Adenoviral-mediated catalase gene transfer protects porcine and human islets in vitro against oxidative stress.
|
Transplant Proc
|
1998
|
0.75
|
|
94
|
[Study of a detection strategy for silent ischemia in diabetic patients: 18 month follow-up of the ARCADIA register].
|
Arch Mal Coeur Vaiss
|
2007
|
0.75
|
|
95
|
[Pancreas transplantation].
|
Rev Prat
|
1991
|
0.75
|
|
96
|
[Heterogeneity of nephropathies in type 2 diabetes].
|
Presse Med
|
2000
|
0.75
|
|
97
|
[Delirium outburst and craniopharyngioma of the 3d ventricle. Association in the development and regression of the 2 pathologies. Apropos of a case].
|
Ann Med Psychol (Paris)
|
1983
|
0.75
|
|
98
|
Better analyze the determinants of therapeutic inertia to overcome it.
|
Diabetes Metab
|
2012
|
0.75
|
|
99
|
[Therapeutic management].
|
Nephrologie
|
2000
|
0.75
|
|
100
|
[Peripheral diabetic neuropathy. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].
|
Diabetes Metab
|
1997
|
0.75
|
|
101
|
Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
|
Diabetes Metab
|
2002
|
0.75
|
|
102
|
[Recent physiopathologic findings and therapeutic perspectives in type II diabetes].
|
Journ Annu Diabetol Hotel Dieu
|
1987
|
0.75
|
|
103
|
Metabolic disturbances after acute vascular events: a comparative study of acute coronary syndrome and ischaemic atherothrombotic stroke.
|
Diabetes Metab
|
2012
|
0.75
|
|
104
|
A need for therapeutic research in diabetic foot lesions healing.
|
Diabetes Metab
|
2000
|
0.75
|
|
105
|
[Health costs associated with the diabetic foot in developed countries.A plea for the creation of health care networks].
|
Diabetes Metab
|
2000
|
0.75
|
|
106
|
[Severe hypercalcemia with hypophosphoremia of thyrotoxic origin].
|
Nouv Presse Med
|
1978
|
0.75
|
|
107
|
[Segmental arterial compliance of the radial artery: physiological role of age, hypertension and type I insulin-dependent-diabetes].
|
Arch Mal Coeur Vaiss
|
1993
|
0.75
|
|
108
|
[Physiopathology of insulin resistance, obesity and type II diabetes in animals].
|
Journ Annu Diabetol Hotel Dieu
|
1988
|
0.75
|
|
109
|
[Methods of computerized approach of dysautonomia from a non-invasive pressure signal].
|
Arch Mal Coeur Vaiss
|
1992
|
0.75
|
|
110
|
[Concerning the recommendations for drug treatment of type 2 diabetes (I). An interview with Pr S. Halimi].
|
Presse Med
|
1999
|
0.75
|
|
111
|
Magnetic resonance angiographic patterns of renal artery stenosis in patients with chronic uraemia: differences between type 2 diabetic and non-diabetic patients.
|
Nephrol Dial Transplant
|
2001
|
0.75
|
|
112
|
[Glycemic control in the intensive care unit: specifities in diabetic patients].
|
Ann Fr Anesth Reanim
|
2009
|
0.75
|